Xinyu Dai

State Key Laboratory Of Oral Diseases & National Center For Stomatology & National Clinical Research Center For Oral Diseases
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Engineered hierarchical 3D scaffold promotes bone regeneration through enhanced mechanotransduction.

Engineered hierarchical 3D scaffold promotes bone regeneration through enhanced mechanotransduction.

Journal: Regenerative biomaterials

Published: April 02, 2026

PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer.

PARK2-Mediated PGK1 Degradation Suppresses Partial Epithelial-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer.

Journal: Oncology research

Published: February 25, 2026

Targeting copper metabolic homeostasis to enable cuproptosis-based cancer therapy.

Targeting copper metabolic homeostasis to enable cuproptosis-based cancer therapy.

Journal: Chinese medical journal

Published: September 22, 2025

Unexpected hydrophilicity and bio-selectivity of fluorinated PEEK: enhancing bone regeneration through macrophage and BMSC cooperation.

Unexpected hydrophilicity and bio-selectivity of fluorinated PEEK: enhancing bone regeneration through macrophage and BMSC cooperation.

Journal: Materials horizons

Published: August 26, 2025

Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy.

Targeting the MHC-I endosomal-lysosomal trafficking pathway in cancer: From mechanism to immunotherapy.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: February 29, 2024

Regulation of Ferroptosis by Amino Acid Metabolism in Cancer.

Regulation of Ferroptosis by Amino Acid Metabolism in Cancer.

Journal: International journal of biological sciences

Published: July 15, 2021

Identification and characteristic analysis of enhancers across 13 major cancer types.

Identification and characteristic analysis of enhancers across 13 major cancer types.

Journal: Precision clinical medicine

Published: May 26, 2021

Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.

Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.

Journal: Cancer letters

Published: May 21, 2018

EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy.

EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy.

Journal: Cell death & disease

Published: March 30, 2017

Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.

Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.

Journal: Scientific reports

Published: August 26, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026